Cargando…
Exposure‐Response Modeling and Simulation to Support Human Dosing of Botulism Antitoxin Heptavalent Product
Botulism antitoxin heptavalent (A, B, C, D, E, F, and G – Equine; BAT) product is a sterile solution of F(ab')(2) and F(ab')(2)‐related antibody fragments prepared from plasma obtained from horses that have been immunized with a specific serotype of botulinum toxoid and toxin. BAT product...
Autores principales: | Beliveau, Martin, Anderson, Deborah, Barker, Doug, Kodihalli, Shantha, Simard, Emilie, Hall, Christine, Richardson, Jason S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323444/ https://www.ncbi.nlm.nih.gov/pubmed/35467014 http://dx.doi.org/10.1002/cpt.2620 |
Ejemplares similares
-
Therapeutic efficacy of equine botulism heptavalent antitoxin against all seven botulinum neurotoxins in symptomatic guinea pigs
por: Barker, Douglas, et al.
Publicado: (2019) -
Cost savings associated with timely treatment of botulism with botulism antitoxin heptavalent product
por: Anderson, Deborah M., et al.
Publicado: (2019) -
Efficacy of equine botulism antitoxin in botulism poisoning in a guinea pig model
por: Emanuel, Andrew, et al.
Publicado: (2019) -
Therapeutic efficacy of equine botulism antitoxin in Rhesus macaques
por: Kodihalli, Shantha, et al.
Publicado: (2017) -
Use of Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)—(Equine) (BAT(®)) in Clinical Study Subjects and Patients: A 15-Year Systematic Safety Review
por: Parrera, Geraldine S., et al.
Publicado: (2021)